Avita Therapeutics Inc (NASDAQ:RCEL)

29.72
Delayed Data
As of 3:59pm ET
 -0.03 / -0.10%
Today’s Change
20.00
Today|||52-Week Range
55.35
-34.68%
Year-to-Date

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Avita Therapeutics Inc have a median target of 10.64, with a high estimate of 60.00 and a low estimate of 6.27. The median estimate represents a -64.20% decrease from the last price of 29.72.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in Avita Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
--
Sales
$6.0M
Reporting Date
TBD

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly --
Growthannually 3.39%
 
 
 
 
 
 

Sales

Growthquarterly 13.69%
 
 
 
 
 
 
Growthannually 36.68%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.